Neta Erez
- Oncology top 0.5%
- Cancer Cells and Metastasis 16
- Cancer-related Molecular Pathways 7
- Chemokine receptors and signaling 6
- Cancer Immunotherapy and Biomarkers 6
- Cancer Research top 1%
- Immunology top 1%
- Immune cells in cancer 16
- Immunotherapy and Immune Responses 8
- Molecular Biology top 2%
- Biotechnology top 2%
-
- Brain Metastases and Treatment 6
-
- Cancer, Stress, Anesthesia, and Immune Response 5
- Co-authors
- Douglas HanahanLea MonteranMorgan TruittPeter OlsonYael RazNoam CohenMichael MilyavskyVarda Rotter
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Neta Erez
60 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 3.1k
- Cancer Research 1.4k
- Immunology 1.9k
- Molecular Biology 2.6k
- Biotechnology 266
Countries citing papers authored by Neta Erez
This map shows the geographic impact of Neta Erez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neta Erez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neta Erez more than expected).
Fields of papers citing papers by Neta Erez
This network shows the impact of papers produced by Neta Erez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neta Erez. The network helps show where Neta Erez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Neta Erez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 17 | |
| 2 | 2023 | 62 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 1 | |
| 5 | Cancer-associated fibroblasts in the single-cell erabreakdown → | 2022 | 371 |
| 6 | 2022 | 87 | |
| 7 | 2021 | 22 | |
| 8 | 2021 | 34 | |
| 9 | 2020 | 110 | |
| 10 | 2020 | 47 | |
| 11 | 2019 | 39 | |
| 12 | 2019 | 187 | |
| 13 | 2019 | 15 | |
| 14 | 2016 | 68 | |
| 15 | 2015 | 140 | |
| 16 | 2013 | 143 | |
| 17 | 2007 | 19 | |
| 18 | 2005 | 51 | |
| 19 | 2004 | 119 | |
| 20 | 2001 | 60 |
About Neta Erez
Neta Erez is a scholar working on Oncology, Immunology, Cancer Research, Aging and Neurology, having authored 61 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (16 papers), Immune cells in cancer (16 papers), Immunotherapy and Immune Responses (8 papers), Cancer-related Molecular Pathways (7 papers), Brain Metastases and Treatment (6 papers), Chemokine receptors and signaling (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). The work is most often cited by research in Oncology (3.1k citations), Cancer Research (1.4k citations), Immunology (1.9k citations), Molecular Biology (2.6k citations) and Biotechnology (266 citations). Neta Erez has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Douglas Hanahan, Lea Monteran, Morgan Truitt, Peter Olson, Yael Raz, Noam Cohen, Michael Milyavsky, Varda Rotter, Dor Lavie and Ruth Scherz‐Shouval. Their work appears in journals such as Cancer Research, Oncogene, Oncotarget, International Journal of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.